Despite the fact that our cohort was not selected for age at diagnosis, the prevalence of germline BRCA1/2 pathogenic variants observed does not differ significantly from that observed in the Rwandan BC patients diagnosed with the disease before 35 years.12 The gene discussed is BRCA1; the disease is breast cancer.